Startups Targeting Antibiotic Resistance Crisis.

October 10, 2018

CNBC (10/9, Ioannou) reports on the growing problem of antibiotic resistance. The article profiles Peter Thiel’s “seed-stage fund” Breakout Labs and its investments in SciBac, a company that is “developing a microbe pill to boost the body’s microbiome in...